The company, which is developing brain-computer interface (BCI) technology, has begun preliminary discussions with potential investors. However, the terms of the funding round have not yet been finalized, and Neuralink has yet to comment officially on the report. Reuters also noted that the company did not immediately respond to requests for confirmation.
A Leap Forward in Human-Computer Interaction
Founded by Musk in 2016, Neuralink aims to revolutionize the way humans interact with machines—particularly for those with severe neurological conditions. Its core product, a coin-sized brain implant, is designed to interpret neural activity and translate it into digital commands.
Earlier this year, Neuralink began human trials and successfully implanted the device in its first patient, who has since demonstrated remarkable capabilities. According to updates shared by Musk and the company, the patient has been able to:
- Control a computer cursor using only their thoughts
- Play video games
- Browse the internet
- Post on social media platforms
The implant is intended to restore functionality for individuals suffering from paralysis and other spinal cord injuries. These advancements have generated excitement—and scrutiny—within the scientific and medical communities.
High Stakes and High Valuation
If the $500 million target is met, the new round would further cement Neuralink's place among the most valuable private health-tech startups. The $8.5 billion pre-money valuation represents investor confidence not just in Neuralink’s technology, but also in its potential to lead the emerging field of human-machine interface solutions.
Neuralink last raised funds in 2021, securing $205 million in a Series C round from backers such as Google Ventures and Founders Fund.
Regulatory and Ethical Spotlight
Neuralink has faced both regulatory hurdles and ethical debates around human trials and the long-term implications of its technology. In 2023, the company received FDA approval to begin human testing—a major milestone that followed years of animal trials and safety reviews.
While Musk envisions a future where brain implants could enhance memory, cognition, and even facilitate telepathic communication, experts have urged caution, citing the complexity of the brain and the risks of invasive procedures.